Zydus Lifesciences [ZYDUSLIFE] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Zydus Lifesciences
NSE
Loading...

Torrent
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zydus Lifesciences wins in 11 metrics, Torrent wins in 9 metrics, with 0 ties. Zydus Lifesciences appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Zydus Lifesciences | Torrent | Better |
---|---|---|---|
P/E Ratio (TTM) | 20.82 | 60.57 | Zydus Lifesciences |
Price-to-Book Ratio | 3.93 | 15.93 | Zydus Lifesciences |
Debt-to-Equity Ratio | 12.21 | 42.81 | Zydus Lifesciences |
PEG Ratio | 1.16 | 3.94 | Zydus Lifesciences |
EV/EBITDA | 13.79 | 32.51 | Zydus Lifesciences |
Profit Margin (TTM) | 19.47% | 16.92% | Zydus Lifesciences |
Operating Margin (TTM) | 29.23% | 26.15% | Zydus Lifesciences |
EBITDA Margin (TTM) | 29.23% | 26.15% | Zydus Lifesciences |
Return on Equity | 19.28% | 25.18% | Torrent |
Return on Assets (TTM) | 11.21% | 12.75% | Torrent |
Free Cash Flow (TTM) | $50.64B | $19.73B | Zydus Lifesciences |
Dividend Yield | 1.44% | 17.47% | Torrent |
1-Year Return | -28.04% | 7.03% | Torrent |
Price-to-Sales Ratio (TTM) | 4.06 | 10.22 | Zydus Lifesciences |
Enterprise Value | $941.85B | $1,234.95B | Torrent |
EV/Revenue Ratio | 4.05 | 10.44 | Zydus Lifesciences |
Gross Profit Margin (TTM) | 73.02% | 75.26% | Torrent |
Revenue per Share (TTM) | $231 | $350 | Torrent |
Earnings per Share (Diluted) | $44.96 | $58.99 | Torrent |
Beta (Stock Volatility) | 0.46 | 0.13 | Torrent |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zydus Lifesciences vs Torrent Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Zydus Lifesciences | -0.88% | -1.36% | -4.79% | 7.15% | -2.95% | -3.87% |
Torrent | -0.65% | -2.85% | 7.55% | 12.16% | 11.91% | 4.52% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Zydus Lifesciences | -28.04% | 141.99% | 136.73% | 135.87% | 653.14% | 2,720.58% |
Torrent | 7.03% | 132.03% | 25.86% | 128.20% | 1,239.63% | 4,934.80% |
Performance & Financial Health Analysis: Zydus Lifesciences vs Torrent
Metric | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Market Information | ||
Market Cap | ₹942.88B | ₹1.21T |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 892,866 | 496,500 |
90 Day Avg. Volume | 869,193 | 588,491 |
Last Close | ₹936.15 | ₹3,573.20 |
52 Week Range | ₹795.00 - ₹1,324.30 | ₹2,886.45 - ₹3,787.90 |
% from 52W High | -29.31% | -5.67% |
All-Time High | ₹1,324.30 (Aug 05, 2024) | ₹3,787.90 (Jul 30, 2025) |
% from All-Time High | -29.31% | -5.67% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.18% | 0.11% |
Quarterly Earnings Growth | -0.01% | 0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.19% | 0.17% |
Operating Margin (TTM) | 0.29% | 0.26% |
Return on Equity (TTM) | 0.19% | 0.25% |
Debt to Equity (MRQ) | 12.21 | 42.81 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹238.05 | ₹224.28 |
Cash per Share (MRQ) | ₹56.02 | ₹20.33 |
Operating Cash Flow (TTM) | ₹67.77B | ₹27.02B |
Levered Free Cash Flow (TTM) | ₹28.38B | ₹19.11B |
Dividends | ||
Last 12-Month Dividend Yield | 1.44% | 17.47% |
Last 12-Month Dividend | ₹14.00 | ₹552.76 |
Valuation & Enterprise Metrics Analysis: Zydus Lifesciences vs Torrent
Metric | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 20.82 | 60.57 |
Forward P/E | 22.29 | 39.97 |
PEG Ratio | 1.16 | 3.94 |
Price to Sales (TTM) | 4.06 | 10.22 |
Price to Book (MRQ) | 3.93 | 15.93 |
Market Capitalization | ||
Market Capitalization | ₹942.88B | ₹1.21T |
Enterprise Value | ₹941.85B | ₹1.23T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.05 | 10.44 |
Enterprise to EBITDA | 13.79 | 32.51 |
Risk & Other Metrics | ||
Beta | 0.46 | 0.13 |
Book Value per Share (MRQ) | ₹238.05 | ₹224.28 |
Financial Statements Comparison: Zydus Lifesciences vs Torrent
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Revenue/Sales | ₹62.90B | ₹31.28B |
Cost of Goods Sold | ₹16.97B | ₹7.74B |
Gross Profit | ₹45.93B | ₹23.54B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹19.27B | ₹8.31B |
EBITDA | ₹20.71B | ₹9.95B |
Pre-Tax Income | ₹16.72B | ₹7.38B |
Income Tax | ₹4.23B | ₹1.90B |
Net Income (Profit) | ₹12.44B | ₹5.48B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Cash & Equivalents | ₹8.27B | ₹5.73B |
Total Current Assets | ₹170.46B | ₹56.23B |
Total Current Liabilities | ₹90.42B | ₹47.17B |
Long-Term Debt | ₹321.00M | ₹13.38B |
Total Shareholders Equity | ₹263.58B | ₹75.91B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹60.42B | ₹2.99B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 892,866 | 496,500 |
Average Daily Volume (90 Day) | 869,193 | 588,491 |
Shares Outstanding | 1.01B | 338.45M |
Float Shares | 248.90M | 103.96M |
% Held by Insiders | 0.75% | 0.71% |
% Held by Institutions | 0.14% | 0.15% |
Dividend Analysis & Yield Comparison: Zydus Lifesciences vs Torrent
Metric | ZYDUSLIFE | TORNTPHARM |
---|---|---|
Last 12-Month Dividend | ₹14.00 | ₹552.76 |
Last 12-Month Dividend Yield | 1.44% | 17.47% |
3-Year Avg Annual Dividend | ₹9.50 | ₹198.92 |
3-Year Avg Dividend Yield | 0.79% | 3.27% |
3-Year Total Dividends | ₹28.50 | ₹596.76 |
Ex-Dividend Date | Jul 25, 2025 | Jun 20, 2025 |